The Economic Burden of Childhood Pneumococcal Diseases in The Gambia
This article, published in Cost Effectiveness and Resource Allocation, presents the results of a study that aimed to estimate, from a societal perspective, the costs incurred by health providers and families of children with pneumococcal diseases in The Gambia. The results indicated that the economic burden of pneumococcal disease in The Gambia is substantial, with costs to families reaching approximately one-third to a half of the provider costs, and accounting for up to 30 percent of total societal costs. The authors conclude that the introduction of pneumococcal conjugate vaccine in The Gambia has the potential to significantly reduce this economic burden in this society.
Author: Usuf E, Mackenzie G, Sambou S, Atherly D, Suraratdecha C
» Visit web page (English)
(Located at resource-allocation.biomedcentral.com)
Citation: Usuf E, Mackenzie G, Sambou S, Atherly D, Suraratdecha C. The Economic Burden of Childhood Pneumococcal Diseases in The Gambia. Cost Effectiveness and Resource Allocation. 2016;14(4):eCollection.
Resource types: Peer-reviewed journal